Related Articles
Evaluation of MMP‑2, MMP‑9, TIMP‑1, TIMP‑2, NGAL and MMP‑9/NGAL complex in urine and sera from patients with bladder cancer
Matrix metalloproteinase-2 and -9 in the sera and in the urine of human oncocytoma and renal cell carcinoma
Matrix metalloproteinase‑2 and ‑9 and tissue inhibitor of metalloproteinase‑1 and ‑2 in sera and urine of patients with renal carcinoma
Role of neutrophil gelatinase‑associated lipocalin in renal cell carcinoma (Review)
NGAL protects in nasopharyngeal carcinoma by inducing apoptosis and blocking epithelial‑mesenchymal transition